outcomeCategory,disease,model,comparison,database,nTNF,nComparator,HazardRatio,RobustWaldLower,RobustWaldUpper,indValidHR,indSigHR
Cancer,Hematologic Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.356646056,0.0399464854,3.1841702243,1,0
Cancer,Hematologic Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3137,0.2762540454,0.1030893122,0.7402930138,1,1
Cancer,Hematologic Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,700,2223,1.7106920197,1.0148540007,2.8836336894,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.2887698553,0.032133263,2.5950688374,1,0
Cancer,Hematologic Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3137,0.218416378,0.0731243853,0.6523913189,1,1
Cancer,Hematologic Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,700,2223,1.7896593596,1.0223278531,3.1329290439,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.2901146351,0.0322645754,2.6086350276,1,0
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3137,0.2173104834,0.07269153,0.6496471623,1,1
Cancer,Hematologic Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,700,2223,1.7902804918,1.0227329256,3.1338623791,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.2863575848,0.0318670415,2.5732123991,1,0
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3137,0.2167641337,0.0725873455,0.6473124118,1,1
Cancer,Hematologic Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,700,2223,1.7691699265,1.0097582483,3.0997144458,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.2889771259,0.0321541108,2.5971105177,1,0
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3137,0.2198647206,0.0736020646,0.6567817846,1,1
Cancer,Hematologic Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,700,2223,1.7705247536,1.0138907958,3.0918101989,1,1
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.2875310731,0.0319857478,2.5847173737,1,0
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3137,0.2166656305,0.0724726061,0.6477481351,1,1
Cancer,Hematologic Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,700,2223,1.7585066783,1.0065424696,3.0722456638,1,1
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.2880314472,0.032044104,2.5889977958,1,0
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3137,0.2154207185,0.072429903,0.6407034113,1,1
Cancer,Hematologic Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,700,2223,1.7897402266,1.0222476614,3.1334579669,1,1
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.1753711445,0.5088588404,2.7148930464,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,1.0700405878,0.672067121,1.7036793257,1,0
Cancer,Non Melanoma Skin Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,1.071896019,0.8339437811,1.3777440418,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,2.2216965678,0.8746814469,5.643123742,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,1.0325365878,0.5908601071,1.8043726294,1,0
Cancer,Non Melanoma Skin Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,1.063564715,0.7934565658,1.4256229663,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,2.2377460259,0.8809550517,5.6841802167,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,1.0422277869,0.5957967971,1.8231698545,1,0
Cancer,Non Melanoma Skin Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,1.0686382095,0.7988800602,1.4294857009,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,2.1966365862,0.8638064745,5.5859876421,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,1.0184218317,0.5828142878,1.7796115315,1,0
Cancer,Non Melanoma Skin Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,1.0456505212,0.7786064639,1.4042845304,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,2.2202673613,0.8740504674,5.6399342368,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,1.0250898081,0.5863753209,1.7920418498,1,0
Cancer,Non Melanoma Skin Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,1.0778847052,0.7987828388,1.4545072594,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,2.2118144547,0.8697440482,5.6247848921,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,1.020464378,0.5835061468,1.7846385208,1,0
Cancer,Non Melanoma Skin Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,1.0653674642,0.7910291136,1.4348496335,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,2.2090677048,0.8708310447,5.6038196547,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,1.031901177,0.5907355032,1.8025326617,1,0
Cancer,Non Melanoma Skin Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,1.0640259194,0.7946397357,1.4247351425,1,0
Cancer,Solid Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,532,742,0.4277778607,0.2117307775,0.8642763243,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2825,3087,0.604697472,0.4314819315,0.8474492349,1,1
Cancer,Solid Cancer,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,647,2102,0.6735805651,0.5259911021,0.86258261,1,1
Cancer,Solid Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,532,742,0.4439355796,0.2020424596,0.9754325861,1,1
Cancer,Solid Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2825,3087,0.769088183,0.4967470343,1.19074014,1,0
Cancer,Solid Cancer,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,647,2102,0.7665082718,0.5800659423,1.0128761024,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,532,742,0.4452904315,0.2025975318,0.9787067325,1,1
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2825,3087,0.7706200809,0.4974737526,1.1937419935,1,0
Cancer,Solid Cancer,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,647,2102,0.7680810973,0.5811720746,1.015101375,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,532,742,0.4409048434,0.200425872,0.9699200953,1,1
Cancer,Solid Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2825,3087,0.7645704202,0.4938398228,1.1837197011,1,0
Cancer,Solid Cancer,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,647,2102,0.7565135305,0.5724000218,0.9998474843,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,532,742,0.4440081108,0.202070321,0.9756168126,1,1
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2825,3087,0.7711820951,0.4979485866,1.1943438335,1,0
Cancer,Solid Cancer,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,647,2102,0.7628280742,0.5772816735,1.0080116823,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,532,742,0.4426520552,0.2011613963,0.9740479316,1,1
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2825,3087,0.7673359603,0.4952921381,1.1888023871,1,0
Cancer,Solid Cancer,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,647,2102,0.7549544745,0.5713034668,0.9976418692,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,532,742,0.4431301573,0.2015875574,0.974089566,1,1
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2825,3087,0.7674706708,0.494544765,1.1910170166,1,0
Cancer,Solid Cancer,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,647,2102,0.7658022572,0.5789622354,1.0129384289,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,536,747,0.5858776857,0.2064465922,1.6626705191,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2836,3127,0.7298604673,0.4042680324,1.3176809912,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,672,2186,0.8987363746,0.6712578369,1.203303748,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,536,747,1.7414770713,0.4703325504,6.4480810164,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2836,3127,0.8569516057,0.4039912635,1.8177770685,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,672,2186,1.0031880887,0.7274184853,1.3835039411,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,536,747,1.746048459,0.471599976,6.4645576265,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2836,3127,0.8601657271,0.4053793656,1.8251670923,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,672,2186,1.006822569,0.7290188255,1.3904876664,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,536,747,1.7199023379,0.4652883979,6.3574850892,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2836,3127,0.8486653856,0.4005238794,1.7982272062,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,672,2186,0.987306398,0.7156427873,1.3620956446,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,536,747,1.7414986649,0.4703391748,6.4481501055,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2836,3127,0.857069903,0.4035758567,1.8201505525,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,672,2186,1.0028840185,0.7272483676,1.38298881,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,536,747,1.7253908202,0.4667905984,6.3775352217,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2836,3127,0.8509746951,0.401007554,1.8058461107,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,672,2186,0.989939778,0.7166278963,1.3674889982,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,536,747,1.7168956931,0.4681935615,6.2959661624,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2836,3127,0.8456390796,0.4006374561,1.7849191134,1,0
Cardiac disease,Aortic Insufficiency/Aortic Regurgitation,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,672,2186,1.004590251,0.7263504884,1.389414048,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.3131654626,0.0680127571,1.4419736998,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2840,3131,0.6244241965,0.3750526768,1.0396021716,1,0
Cardiac disease,Conduction Block,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,680,2192,0.8115480507,0.5974650439,1.1023410411,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.2248434132,0.0460533997,1.09773786,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2840,3131,1.1040812339,0.5425566341,2.2467615258,1,0
Cardiac disease,Conduction Block,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,680,2192,0.8812808666,0.6140879626,1.2647308091,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.2252410846,0.0461249083,1.0999164669,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2840,3131,1.1039129707,0.5422522808,2.2473374297,1,0
Cardiac disease,Conduction Block,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,680,2192,0.8824799907,0.6136020665,1.2691791251,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.2223544406,0.0454317573,1.0882585267,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2840,3131,1.0915857774,0.5360522348,2.2228421635,1,0
Cardiac disease,Conduction Block,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,680,2192,0.8647613507,0.6030695158,1.2400099391,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.2246307291,0.0460081266,1.0967402533,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2840,3131,1.0950156669,0.5409416626,2.2166148288,1,0
Cardiac disease,Conduction Block,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,680,2192,0.8915130063,0.6196074176,1.2827403575,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.2225884116,0.0454704587,1.0896217538,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2840,3131,1.083377134,0.5347965399,2.1946776521,1,0
Cardiac disease,Conduction Block,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,680,2192,0.8746397933,0.6077077812,1.2588200968,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.2218128409,0.0456083471,1.0787704343,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2840,3131,1.0777903423,0.5377904811,2.1600085214,1,0
Cardiac disease,Conduction Block,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,680,2192,0.8763606437,0.6076818825,1.2638322778,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,434916.79347,140394.4087,1347294.5183,0,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3137,1.0987494266,0.4242308825,2.845738847,1,0
Cardiac disease,Myocardial infarction,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,695,2225,0.8501652596,0.5263491835,1.3731967129,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,833604.26348,245940.43281,2825464.9313,0,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3137,0.8067147258,0.2936202871,2.2164294407,1,0
Cardiac disease,Myocardial infarction,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,695,2225,1.1752228868,0.6767204248,2.0409445071,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,865649.49671,254953.4515,2939160.2535,0,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3137,0.8029090675,0.2922407334,2.2059312651,1,0
Cardiac disease,Myocardial infarction,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,695,2225,1.1830366806,0.6793693854,2.0601101813,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,827767.12364,241824.366,2833454.8015,0,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3137,0.7986814571,0.2907710557,2.1937949371,1,0
Cardiac disease,Myocardial infarction,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,695,2225,1.152175655,0.6627342321,2.0030785734,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1063450.9619,313808.30012,3603881.5669,0,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3137,0.7909636297,0.2871558015,2.1786899659,1,0
Cardiac disease,Myocardial infarction,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,695,2225,1.2086351987,0.6860398002,2.1293211314,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1108869.5026,323418.04207,3801864.5029,0,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3137,0.7810002735,0.2831711012,2.1540384055,1,0
Cardiac disease,Myocardial infarction,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,695,2225,1.1890552473,0.6733728006,2.0996576934,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1217871.471,362505.58771,4091553.2623,0,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3137,0.7871482667,0.2867688433,2.1606335848,1,0
Cardiac disease,Myocardial infarction,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,695,2225,1.1814231003,0.6777674286,2.0593502773,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.6602396879,0.8869462055,3.1077373174,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,1.1099188317,0.9090886358,1.3551151829,1,0
Infection,Hospitalized infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.9239661766,0.7806675394,1.0935685839,1,0
Infection,Hospitalized infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,4.1524781537,1.8856627653,9.1443046628,1,1
Infection,Hospitalized infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,1.166357713,0.8651778759,1.5723822264,1,0
Infection,Hospitalized infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.9411696512,0.7783061573,1.1381129445,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,4.170279643,1.8921195322,9.1914025541,1,1
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,1.1646091752,0.8624090758,1.5727043802,1,0
Infection,Hospitalized infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.9361220427,0.7746620229,1.1312345938,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,4.1520621537,1.8851679606,9.1448722277,1,1
Infection,Hospitalized infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,1.1661247274,0.8653773759,1.5713917624,1,0
Infection,Hospitalized infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.9408515944,0.7782316538,1.1374527346,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,4.149338962,1.8874605257,9.1217874954,1,1
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,1.1526595797,0.8639688749,1.5378147817,1,0
Infection,Hospitalized infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.966515207,0.7969321881,1.1721846092,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,4.1603135613,1.8909242113,9.1533065286,1,1
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,1.1536446776,0.8627009779,1.5427083963,1,0
Infection,Hospitalized infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.9560734404,0.7886142795,1.1590918999,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,4.1534894352,1.8845310484,9.1542532572,1,1
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,1.1590758531,0.8583148193,1.5652261887,1,0
Infection,Hospitalized infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.9362131399,0.7746554353,1.1314643947,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.2104869762,0.4068575141,3.6014542403,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,1.2777845044,0.8783654299,1.8588313978,1,0
Infection,Opportunistic infection,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.8900486496,0.634198659,1.2491142756,1,0
Infection,Opportunistic infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.9348597111,0.298705438,2.9258345123,1,0
Infection,Opportunistic infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,0.7847314211,0.4803707938,1.2819334798,1,0
Infection,Opportunistic infection,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.8230331636,0.5652838057,1.1983070833,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.9377016616,0.2992643836,2.938152531,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,0.7853479306,0.4823924795,1.2785675532,1,0
Infection,Opportunistic infection,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.8284133169,0.5685479432,1.2070549754,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.9460388129,0.3022936413,2.9606624589,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,0.7914104982,0.4853277055,1.2905312627,1,0
Infection,Opportunistic infection,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.8358885337,0.5741977294,1.2168450082,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.9344191396,0.2985322145,2.924773562,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,0.7803632965,0.4773915733,1.275612953,1,0
Infection,Opportunistic infection,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.8304790263,0.5707159118,1.2084741266,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.9483250052,0.3025191089,2.9727719313,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,0.7899677493,0.4858318981,1.2844958253,1,0
Infection,Opportunistic infection,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.8419577794,0.5781220798,1.226199322,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.936399289,0.2989283638,2.9332901614,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,0.7814062869,0.4800549905,1.2719288359,1,0
Infection,Opportunistic infection,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.8286708245,0.5684878902,1.2079330927,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,517,737,1.3589651128,0.6383622291,2.8930066563,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2750,3090,1.2399342343,0.8639243597,1.7795966604,1,0
Inflammatory bowel disease,Crohn’s Disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,674,2206,1.5868689959,0.9495235421,2.6520176682,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,517,737,1.4906368136,0.6273440872,3.5419128916,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2750,3090,1.1676576968,0.7623103198,1.7885426205,1,0
Inflammatory bowel disease,Crohn’s Disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,674,2206,1.466865714,0.8337883119,2.5806250727,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,517,737,1.5022876362,0.6295251935,3.5850322831,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2750,3090,1.1682959279,0.7629343165,1.7890339255,1,0
Inflammatory bowel disease,Crohn’s Disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,674,2206,1.4721747789,0.8355281311,2.5939265226,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,517,737,1.4896985515,0.626840487,3.5402974443,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2750,3090,1.1666872967,0.7622405387,1.7857345276,1,0
Inflammatory bowel disease,Crohn’s Disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,674,2206,1.4646815608,0.8317160579,2.5793563248,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,517,737,1.4919324619,0.6278562883,3.5451782716,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2750,3090,1.1795661787,0.7702252757,1.8064537918,1,0
Inflammatory bowel disease,Crohn’s Disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,674,2206,1.4424596522,0.8200142854,2.5373824399,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,517,737,1.5041249023,0.6298259702,3.592090242,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2750,3090,1.1796189807,0.7711069413,1.8045498816,1,0
Inflammatory bowel disease,Crohn’s Disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,674,2206,1.4499202031,0.8220175743,2.5574496957,1,0
Inflammatory bowel disease,Crohn’s Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,517,737,1.4875699133,0.621239285,3.5620159579,1,0
Inflammatory bowel disease,Crohn’s Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2750,3090,1.1508104673,0.753181595,1.7583604542,1,0
Inflammatory bowel disease,Crohn’s Disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,674,2206,1.4565777775,0.8257668872,2.5692708861,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,528,740,0.9067482218,0.2967713515,2.7704572347,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2806,3125,1.3022233098,0.8694308916,1.9504546766,1,0
Inflammatory bowel disease,Ulcerative Colitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,680,2210,1.8073716085,1.1237450562,2.9068800911,1,1
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,528,740,0.6251970283,0.1873092007,2.0867705526,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2806,3125,1.0578949899,0.663977896,1.6855106417,1,0
Inflammatory bowel disease,Ulcerative Colitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,680,2210,1.8025488049,1.0553851514,3.0786696114,1,1
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,528,740,0.6316539952,0.1889051886,2.1121006394,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2806,3125,1.0684977867,0.6698347524,1.7044316022,1,0
Inflammatory bowel disease,Ulcerative Colitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,680,2210,1.8217995371,1.0621853082,3.1246464508,1,1
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,528,740,0.6261099685,0.1874749926,2.0910185793,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2806,3125,1.0594175608,0.6646323177,1.6887014644,1,0
Inflammatory bowel disease,Ulcerative Colitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,680,2210,1.8062018086,1.0575792512,3.084747521,1,1
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,528,740,0.6254891874,0.1873875444,2.0878480737,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2806,3125,1.0617147965,0.6664671787,1.6913635734,1,0
Inflammatory bowel disease,Ulcerative Colitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,680,2210,1.7900309636,1.0497665102,3.0523081272,1,1
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,528,740,0.6332651831,0.1893064488,2.1183894925,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2806,3125,1.0765622063,0.6742285183,1.7189812542,1,0
Inflammatory bowel disease,Ulcerative Colitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,680,2210,1.8115069629,1.0583163983,3.1007338465,1,1
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,528,740,0.6268504805,0.1874552745,2.0961881492,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2806,3125,1.0588724813,0.6650338204,1.6859457326,1,0
Inflammatory bowel disease,Ulcerative Colitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,680,2210,1.8123336452,1.0569213909,3.1076608627,1,1
Kidney disease,Amyloidosis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,9.7719625E-8,9.7719625E-8,9.7719625E-8,0,0
Kidney disease,Amyloidosis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,2718009.8222,381720.91354,19353347.253,0,0
Kidney disease,Amyloidosis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.8276935564,0.0948948501,7.2193235219,1,0
Kidney disease,Amyloidosis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,4.885941E-8,7.7242489E-9,3.0905814E-7,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,3733143.3308,511961.6701,27221489.308,0,0
Kidney disease,Amyloidosis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.4253619052,0.0494321175,3.660226577,1,0
Kidney disease,Amyloidosis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,4.7267221E-8,1.2329709E-8,1.8120381E-7,0,0
Kidney disease,Amyloidosis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,3635795.5434,503178.78714,26270998.641,0,0
Kidney disease,Amyloidosis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.4176307908,0.0504066713,3.4601665423,1,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,4.8504606E-8,7.2288464E-9,3.2545951E-7,0,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,3731193.7065,503561.4017,27646691.007,0,0
Kidney disease,Amyloidosis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.4212599558,0.0466209586,3.8064414772,1,0
Kidney disease,Amyloidosis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,4.7452568E-8,1.0277399E-8,2.190969E-7,0,0
Kidney disease,Amyloidosis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,3850319.9942,528102.6178,28072127.572,0,0
Kidney disease,Amyloidosis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,0.4167890765,0.0482099188,3.6032654428,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,538,746,1.3988547111,0.0873779531,22.394602218,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,0.9682307223,0.193445369,4.8461782068,1,0
Kidney disease,IgA nephropathy,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,2.0098024296,0.4734126856,8.5323142558,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,538,746,6.4877576503,0.3973765926,105.92219098,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,0.8887917697,0.1762849336,4.4811022348,1,0
Kidney disease,IgA nephropathy,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,2.7236659512,0.6455561881,11.491418331,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,538,746,6.4801798642,0.3978793588,105.5413661,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,0.8810361337,0.1750542728,4.434194359,1,0
Kidney disease,IgA nephropathy,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,2.7496786298,0.6492404029,11.645505322,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,538,746,6.4798072556,0.3963964879,105.92400122,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,0.8848105409,0.1753760753,4.4640621127,1,0
Kidney disease,IgA nephropathy,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,2.7047644605,0.631051931,11.592945727,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,538,746,6.4894674843,0.3975090066,105.94272716,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,0.89217282,0.1780027028,4.4716868247,1,0
Kidney disease,IgA nephropathy,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,2.7066502671,0.6451094939,11.356143008,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,538,746,6.4608275649,0.3990705635,104.59877687,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,0.8806293077,0.1763571806,4.3973711476,1,0
Kidney disease,IgA nephropathy,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,2.7146529476,0.6282159568,11.730584914,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,538,746,6.6236314161,0.4078660307,107.56594036,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3140,0.9006966513,0.1790843085,4.5300141832,1,0
Kidney disease,IgA nephropathy,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,2.801469383,0.6678675386,11.751178566,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,3266518.1888,799096.76551,13352752.18,0,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2853,3140,1.0381119647,0.1430229026,7.5349921709,1,0
Kidney disease,Nephrotic syndrome,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,1.7774235417,0.3362023628,9.3968240434,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,2948687.5672,686166.36403,12671501.876,0,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2853,3140,1.0784020378,0.1484492084,7.833999033,1,0
Kidney disease,Nephrotic syndrome,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,2.899390341,0.4610630963,18.232785093,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,2576951.7706,603331.54443,11006685.278,0,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2853,3140,1.1025165438,0.1492123522,8.1463947957,1,0
Kidney disease,Nephrotic syndrome,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,2.9250685026,0.4645674967,18.417185458,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,2948046.954,683879.88427,12708344.028,0,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2853,3140,1.0791512702,0.1489741488,7.8172452947,1,0
Kidney disease,Nephrotic syndrome,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,2.9052846315,0.4443199673,18.996847794,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,2958018.5741,688272.23673,12712809.58,0,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2853,3140,1.0751080087,0.1479082745,7.8146894382,1,0
Kidney disease,Nephrotic syndrome,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,2.918993568,0.4782991914,17.814212534,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,2604705.1772,606687.41332,11182841.297,0,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2853,3140,1.0925714043,0.1494060912,7.9897162431,1,0
Kidney disease,Nephrotic syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,2.9815300656,0.4795042112,18.538985318,1,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,5921644.0189,1380722.2153,25396757.941,0,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2853,3140,1.1420158517,0.1521047734,8.5743542171,1,0
Kidney disease,Nephrotic syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,702,2239,2.933722377,0.4630445535,18.587254552,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.997445461,0.8804977609,1.1299261529,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3140,2.9538131383,0.3069184641,28.427784819,1,0
Lung disease,Interstitial lung disease,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,699,2234,1.8765629061,0.9310375247,3.7823269709,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.0345972972,0.8662766152,1.2356232969,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3140,3.9165695531,0.3938060031,38.951963518,1,0
Lung disease,Interstitial lung disease,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,699,2234,1.7288174515,0.8218176866,3.636828252,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.6011562926,1.3211182237,1.9405541663,1,1
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3140,3.9901537767,0.4000471138,39.798630243,1,0
Lung disease,Interstitial lung disease,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,699,2234,1.7039093266,0.8075924456,3.5950150465,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.041135498,0.8733817883,1.2411102907,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3140,3.9403112072,0.3959613611,39.211028991,1,0
Lung disease,Interstitial lung disease,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,699,2234,1.7510251376,0.8312067507,3.6887200807,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.0364555654,0.8678010166,1.2378876245,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3140,3.8812970573,0.3900589091,38.621004408,1,0
Lung disease,Interstitial lung disease,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,699,2234,1.7633764083,0.8386942726,3.7075445236,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.6048469682,1.3256789375,1.9428035841,1,1
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3140,3.9907062035,0.3999793324,39.816397276,1,0
Lung disease,Interstitial lung disease,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,699,2234,1.732316404,0.8211780417,3.6544086314,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,0.9904599261,0.8173586456,1.2002208218,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3140,3.9585136924,0.3983640206,39.335456622,1,0
Lung disease,Interstitial lung disease,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,699,2234,1.7087222086,0.8108151945,3.6009828207,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,536,747,0.5699218022,0.1791329392,1.8132391618,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2838,3126,0.9493466823,0.5431816672,1.6592222779,1,0
Lung disease,Restrictive lung disease ,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,681,2198,1.0563103022,0.7505006234,1.4867295505,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,536,747,0.5073577236,0.1412954409,1.8217987642,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2838,3126,1.0019628001,0.5058205556,1.9847541617,1,0
Lung disease,Restrictive lung disease ,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,681,2198,1.1401187212,0.7709089735,1.6861532856,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,536,747,0.509172922,0.1416343817,1.8304670193,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2838,3126,1.0052390122,0.5069466241,1.9933172915,1,0
Lung disease,Restrictive lung disease ,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,681,2198,1.1375812257,0.7674870879,1.6861404778,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,536,747,0.5063449844,0.1410644302,1.8175045462,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2838,3126,0.9990726555,0.5041727538,1.9797701552,1,0
Lung disease,Restrictive lung disease ,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,681,2198,1.1347117778,0.7685775434,1.6752646883,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,536,747,0.5067078834,0.1410574308,1.8202010178,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2838,3126,0.9956575727,0.5024517238,1.9729935337,1,0
Lung disease,Restrictive lung disease ,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,681,2198,1.1564935877,0.7702897882,1.7363301953,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,536,747,0.5073683431,0.1412017691,1.8230836425,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2838,3126,0.9963128814,0.5022547131,1.9763664365,1,0
Lung disease,Restrictive lung disease ,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,681,2198,1.1450189727,0.7627960576,1.7187666806,1,0
Lung disease,Restrictive lung disease ,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,536,747,0.5052637526,0.1408637272,1.8123292972,1,0
Lung disease,Restrictive lung disease ,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2838,3126,0.9952364991,0.5027058811,1.9703284294,1,0
Lung disease,Restrictive lung disease ,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,681,2198,1.1312473324,0.7621952835,1.6789929758,1,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.129031E-7,1.0860771E-8,1.1736838E-6,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3139,6593579.4297,974275.97413,44623177.467,0,0
Neurological Disease,Cauda Equina syndrome,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,701,2238,0.2403238504,0.0285821555,2.0206857025,1,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.0880154E-7,1.5410356E-8,7.6817018E-7,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3139,6649405.1499,976749.02356,45267092.96,0,0
Neurological Disease,Cauda Equina syndrome,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,701,2238,0.240512361,0.028851266,2.0049794662,1,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.1512328E-7,1.41492E-8,9.3668687E-7,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3139,6656490.8205,961781.28348,46069590.669,0,0
Neurological Disease,Cauda Equina syndrome,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,701,2238,0.2429188199,0.0284144507,2.0767444606,1,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.0815171E-7,8.1239266E-9,1.4397953E-6,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3139,6871839.0915,1011826.454,46670229.18,0,0
Neurological Disease,Cauda Equina syndrome,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,701,2238,0.2356428105,0.0280381287,1.9804293892,1,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.0588622E-7,4.6357236E-9,2.4185849E-6,0,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3139,7043193.4287,994929.58223,49859381.569,0,0
Neurological Disease,Cauda Equina syndrome,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,701,2238,0.2400812141,0.0283602561,2.0323860637,1,0
Neurological Disease,Cauda Equina syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.0427472E-7,1.5543212E-8,6.9954758E-7,0,0
Neurological Disease,Cauda Equina syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2854,3139,6869670.8873,983897.17116,47964746.198,0,0
Neurological Disease,Cauda Equina syndrome,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,701,2238,0.2389199189,0.0284805267,2.0042721926,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,4.3384005E-6,6.1178322E-7,0.0000307653,0,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3139,0.9786216522,0.4087251061,2.3431404726,1,0
Neurological Disease,Spinal Cord compression,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,701,2236,0.4488721419,0.1025247833,1.9652438489,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.5665103E-6,2.2098863E-7,0.0000111044,0,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3139,0.6888401019,0.2749929429,1.7255013201,1,0
Neurological Disease,Spinal Cord compression,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,701,2236,0.4047300602,0.0801686777,2.0432720903,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.5634716E-6,2.1901243E-7,0.0000111612,0,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3139,0.6968374453,0.2776748885,1.7487444682,1,0
Neurological Disease,Spinal Cord compression,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,701,2236,0.4069082112,0.0804544089,2.0579890458,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.57047E-6,2.2130482E-7,0.0000111447,0,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3139,0.6902402856,0.2759363409,1.7265998757,1,0
Neurological Disease,Spinal Cord compression,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,701,2236,0.4061569359,0.079482076,2.0754799675,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.5555173E-6,2.1819368E-7,0.0000110894,0,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3139,0.6933667595,0.2768281163,1.736664142,1,0
Neurological Disease,Spinal Cord compression,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,701,2236,0.4001939929,0.0795380699,2.0135669886,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.5564279E-6,2.1852317E-7,0.0000110856,0,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3139,0.7043920966,0.2810105261,1.7656570828,1,0
Neurological Disease,Spinal Cord compression,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,701,2236,0.4053298029,0.0791121052,2.0767017726,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,539,748,1.4561622E-6,2.0403093E-7,0.0000103926,0,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2852,3139,0.6861303307,0.2746631822,1.7140077787,1,0
Neurological Disease,Spinal Cord compression,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,701,2236,0.4030594682,0.079532437,2.0426500316,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,538,746,1.1732156201,0.3569437858,3.8561671221,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2849,3135,0.60973743,0.3205772389,1.1597196822,1,0
Osteoporotic fracture,Clinical vertebral fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,693,2211,0.9429465454,0.6708735507,1.3253588348,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,538,746,1.2990118941,0.3417188888,4.938070315,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2849,3135,1.0402095042,0.4806903309,2.2510039066,1,0
Osteoporotic fracture,Clinical vertebral fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,693,2211,0.9197080727,0.6291911723,1.3443655544,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,538,746,1.2998573179,0.3423374047,4.935566561,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2849,3135,1.0394372308,0.4803908646,2.2490639113,1,0
Osteoporotic fracture,Clinical vertebral fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,693,2211,0.9132060616,0.6213734769,1.3420999477,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,538,746,1.3033642469,0.3429685218,4.9531028417,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2849,3135,1.0442267312,0.4821240676,2.2616781437,1,0
Osteoporotic fracture,Clinical vertebral fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,693,2211,0.9262585124,0.6322504212,1.3569857814,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,538,746,1.2991159846,0.3417455492,4.9384764347,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2849,3135,1.0407774113,0.4808408362,2.2527571251,1,0
Osteoporotic fracture,Clinical vertebral fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,693,2211,0.9189166105,0.6297606238,1.3408392096,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,538,746,1.3046421252,0.3437443812,4.9516186093,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2849,3135,1.0445146825,0.482233804,2.2624107077,1,0
Osteoporotic fracture,Clinical vertebral fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,693,2211,0.9180545166,0.6236745082,1.3513845514,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,538,746,1.2924871232,0.3391669468,4.9253707629,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2849,3135,1.0299394584,0.4788119362,2.215432005,1,0
Osteoporotic fracture,Clinical vertebral fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,693,2211,0.9127627208,0.6203944215,1.3429130818,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,536,742,0.6978103474,0.3268091537,1.4899805451,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2838,3126,1.1470037856,0.749704583,1.7548481282,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,685,2188,0.8987647556,0.6553220759,1.2326428723,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,536,742,1.0109578955,0.3935170374,2.5971832709,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2838,3126,1.5666034761,0.9318640873,2.6336957123,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,685,2188,0.8079353437,0.5557924011,1.1744664344,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,536,742,1.0164961201,0.3955121307,2.6124719878,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2838,3126,1.5757796615,0.9374779373,2.6486826438,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,685,2188,0.8108330633,0.5579395671,1.1783538852,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,536,742,1.0179969492,0.3954240552,2.6207757845,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2838,3126,1.5779618802,0.9376571693,2.655516085,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,685,2188,0.8169682227,0.562232126,1.1871201342,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,536,742,1.0097541666,0.3930440318,2.5941202372,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2838,3126,1.5542649492,0.9252324214,2.6109542601,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,685,2188,0.8227064342,0.5633540621,1.201457347,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,536,742,1.020270362,0.3961311953,2.6277950936,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2838,3126,1.5725403793,0.9358276744,2.642455777,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,685,2188,0.8336719503,0.5711688421,1.2168186873,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,536,742,1.0118800497,0.3949379446,2.5925623222,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2838,3126,1.5598690907,0.9267266753,2.6255762838,1,0
Osteoporotic fracture,Non-vertebral osteoporotic fracture,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,685,2188,0.8114856845,0.5585857699,1.1788861292,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,533,742,2.0632000772,0.8822519834,4.8249192281,1,0
PsO/PsA,Psoriasis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2783,3096,1.5123142585,1.0728999491,2.1316940304,1,1
PsO/PsA,Psoriasis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,681,2195,1.6402823101,1.0741435665,2.5048104749,1,1
PsO/PsA,Psoriasis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,533,742,1.40282833,0.521043249,3.7768982274,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2783,3096,1.2518912754,0.8296365603,1.889058222,1,0
PsO/PsA,Psoriasis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,681,2195,1.2328827705,0.7707154518,1.9721933981,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,533,742,1.3996258697,0.5196743653,3.7695770776,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2783,3096,1.2490656567,0.8275385301,1.8853080046,1,0
PsO/PsA,Psoriasis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,681,2195,1.2306100604,0.7680449422,1.9717610748,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,533,742,1.4062380021,0.5226631116,3.7835180537,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2783,3096,1.2545316151,0.831565315,1.8926349439,1,0
PsO/PsA,Psoriasis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,681,2195,1.2376371756,0.775268373,1.9757619836,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,533,742,1.4040870681,0.521366079,3.7813363278,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2783,3096,1.2592360729,0.8346031606,1.8999155074,1,0
PsO/PsA,Psoriasis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,681,2195,1.215850785,0.7612521093,1.9419231993,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,533,742,1.4045971076,0.5217831356,3.7810594101,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2783,3096,1.2567445692,0.8324132688,1.8973831526,1,0
PsO/PsA,Psoriasis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,681,2195,1.2175650858,0.7621107628,1.9452090304,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,533,742,1.3776369013,0.5104393288,3.7181371508,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2783,3096,1.2316542772,0.8165196716,1.8578514533,1,0
PsO/PsA,Psoriasis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,681,2195,1.2210472325,0.7624266221,1.9555407707,1,0
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,521,739,2.2466813856,1.0561199905,4.7793596313,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2735,3079,1.6758465695,1.1862881383,2.3674364044,1,1
PsO/PsA,Psoriatic arthritis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,669,2187,2.458863113,1.5810296909,3.8240950462,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,521,739,3.4312658104,1.2475460837,9.4373949108,1,1
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2735,3079,1.4746643082,0.9787928423,2.2217518642,1,0
PsO/PsA,Psoriatic arthritis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,669,2187,2.0590347796,1.2655214553,3.3501006291,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,521,739,3.4257065379,1.2437321085,9.4356857107,1,1
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2735,3079,1.4799104127,0.9827471822,2.2285841867,1,0
PsO/PsA,Psoriatic arthritis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,669,2187,2.0546216703,1.2626977184,3.3432152023,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,521,739,3.4469333807,1.2556364736,9.4624120759,1,1
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2735,3079,1.480671017,0.9826734931,2.2310428396,1,0
PsO/PsA,Psoriatic arthritis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,669,2187,2.0763351203,1.2766451066,3.3769506573,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,521,739,3.4323468822,1.2479469696,9.4403090893,1,1
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2735,3079,1.4789125855,0.9817401421,2.2278628956,1,0
PsO/PsA,Psoriatic arthritis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,669,2187,2.0420393401,1.2538990832,3.3255664049,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,521,739,3.4439924994,1.2526220763,9.4690047067,1,1
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2735,3079,1.4905480512,0.9895073824,2.2452924886,1,0
PsO/PsA,Psoriatic arthritis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,669,2187,2.0471292876,1.2568038718,3.334440969,1,1
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,521,739,3.4001238775,1.230683562,9.3938383022,1,1
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2735,3079,1.4645720019,0.9729235749,2.2046656121,1,0
PsO/PsA,Psoriatic arthritis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,669,2187,2.0415115521,1.2528719925,3.3265724211,1,1
Uveitis,Uveitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,508,720,0.61838317,0.3505824049,1.0907499623,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2680,3014,0.9750198464,0.767757117,1.2382349571,1,0
Uveitis,Uveitis,"0 Unweighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,667,2175,1.4855235826,1.0230018297,2.1571616497,1,1
Uveitis,Uveitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",MPCD,508,720,0.5787088533,0.3020936589,1.1086096217,1,0
Uveitis,Uveitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Marketscan,2680,3014,1.0640779668,0.8107593702,1.3965449689,1,0
Uveitis,Uveitis,"a Weighted, no covariates","TNF vs DMARD, NSAID, or no exposure",Medicare,667,2175,1.5153628436,0.9961946551,2.305096234,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,508,720,0.5792785631,0.302598982,1.1089384754,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2680,3014,1.0687539279,0.8142292491,1.4028419634,1,0
Uveitis,Uveitis,"b Weighted, covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,667,2175,1.5193643289,0.9987708063,2.3113090106,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",MPCD,508,720,0.5776272568,0.3014130995,1.1069633282,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2680,3014,1.0617315873,0.808571409,1.3941551124,1,0
Uveitis,Uveitis,"c Weighted, covariates (sex)","TNF vs DMARD, NSAID, or no exposure",Medicare,667,2175,1.5098674801,0.9915786689,2.299060961,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,508,720,0.5789031408,0.3021752853,1.1090544552,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2680,3014,1.073466216,0.8181334461,1.4084862589,1,0
Uveitis,Uveitis,"d Weighted, covariates (indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,667,2175,1.4956481696,0.9837322965,2.2739554806,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",MPCD,508,720,0.5789233651,0.3023212519,1.108596437,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2680,3014,1.0764614687,0.8196987705,1.4136525945,1,0
Uveitis,Uveitis,"e Weighted, covariates (6-month daily steroid dose, sex, indHospInf)","TNF vs DMARD, NSAID, or no exposure",Medicare,667,2175,1.4945017649,0.9819170343,2.2746682737,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",MPCD,508,720,0.5735463738,0.2994776987,1.0984305151,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Marketscan,2680,3014,1.0561659934,0.8050901024,1.3855425652,1,0
Uveitis,Uveitis,"f Weighted (stabilized), covariates (6-month daily steroid dose)","TNF vs DMARD, NSAID, or no exposure",Medicare,667,2175,1.5077760635,0.9894788399,2.2975616718,1,0
